PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and ...

OPEN Health is excited to announce the upcoming presentation of a collection of research supported by its Scientific Buyout ...